Opioid Use, Disability, and Cognition in Migraine: Multi-Country Results From the Chronic Migraine Epidemiology and Outcomes – International Study (S35.009)
To contrast disability and cognitive function in people with migraine who do and do not use opioids to treat their migraine in the Chronic Migraine Epidemiology and Outcomes-International (CaMEO-I) Study.
Authors
- Richard B. Lipton (ORCID: https://orcid.org/0000-0003-2652-2897)
- Fumihiko Sakai (ORCID: https://orcid.org/0000-0001-9385-7991)
- Manjit Singh Matharu (ORCID: https://orcid.org/0000-0002-4960-2294)
- Michel Lantéri‐Minet (ORCID: https://orcid.org/0000-0001-6717-9234)
- Élizabeth Leroux (ORCID: https://orcid.org/0000-0002-2608-261X)
- Janette Contreras‐De Lama (ORCID: https://orcid.org/0009-0005-9032-7676)
- Zaza Katsarava (ORCID: https://orcid.org/0000-0002-9932-1159)
- Kristina M. Fanning (ORCID: https://orcid.org/0000-0001-8072-1489)
- Dawn C. Buse
- Nicole Naccara
Institutions
- Albert Einstein College of Medicine (US)
- AbbVie (United States) (US)
- Centre Hospitalier Universitaire de Nice (FR)
- Saitama International Medical Center (JP)
- IST Research (US)
- AbbVie (Japan)
- University College London (GB)
- University of Duisburg-Essen (DE)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211314
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00